Related Experiment Videos
The pharmacology of antimigrainous drugs
P R Saxena1, M O Den Boer, M D Ferrari
1Department of Pharmacology, Faculty of Medicine & Health Sciences, Erasmus University Rotterdam, The Netherlands.
Clinical Neuropharmacology
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Cluster headache and other trigeminal autonomic cephalalgias].
Nederlands tijdschrift voor geneeskunde·2020
Alcoholic beverages as trigger factor and the effect on alcohol consumption behavior in patients with migraine.
European journal of neurology·2018
[Medication-overuse headache].
Nederlands tijdschrift voor geneeskunde·2018
Benzodiazepine-Sparing Alcohol Withdrawal Protocol Pilot in Postsurgical Head and Neck Cancer Patients.
Clinical neuropharmacology·2026
Retrograde Ejaculation Associated With Paliperidone Palmitate: A Case Report.
Clinical neuropharmacology·2026
Zinc-associated Copper Deficiency Myelopathy: A Case Report.
Clinical neuropharmacology·2026
Candesartan for Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Clinical neuropharmacology·2026
Clozapine-Memantine Therapy in Catatonia: Clinical Insights From a Case Report and Literature Review.
Clinical neuropharmacology·2026
Systematic allergological evaluation enables NSAID allergy delabeling and identification of safe alternatives in adults.
Allergologia et immunopathologia·2026
Canada's crackdown on poppers and trends in crystal methamphetamine use among sexual and gender diverse men: a secondary data analysis.
The International journal on drug policy·2026
A Look Back at Mercury Soap as a Treatment for Yaws.
The American Journal of dermatopathology·2026
Chelidonium majus L. alkaloid extract encapsulated in human serum albumin nanoparticles induces mitochondria-mediated apoptosis in HeLa cell line.
Cellular and molecular biology (Noisy-le-Grand, France)·2026
Reduced severe infection risk with avacopan in ANCA-associated vasculitis: a multicentre REVEAL cohort with time-varying exposure modelling.
Rheumatology (Oxford, England)·2026